Mesothelioma Malignant

Mesothelioma is a malignant neoplasm that develops from mesothelial cells that line the pleura, peritoneum and other body cavities. Mesotheliomas can be either primary or secondary, that is, they occur against the background of other diseases.

Malignant mesotheliomas (coelomic cancer) are the most aggressive form of mesothelioma, which is characterized by rapid growth and metastasis. Symptoms of malignant mesothelioma include chest pain, cough, shortness of breath, weakness, weight loss and other symptoms.

Treatment for malignant mesothelioma includes surgical removal of the tumor, chemotherapy, and radiation therapy. In some cases, a bone marrow transplant may be required. The prognosis for malignant mesothelioma depends on the stage of the disease, the location of the tumor and the effectiveness of treatment.

Mesotheliomas are nonepithelial malignant tumors of the peritoneum. They are characterized by a variety of clinical presentations, morphological forms and degrees of malignancy and can lead to different outcomes of the disease. According to a major study by the World Health Organization (WHO), mesotheliomas (both primary and secondary diseases) account for 3 to 5% of all cancers. Data obtained over the past 20 years suggest with confidence that the incidence of mesothelioma will increase. The incidence is about 6 cases per 1 million population per year [1].